VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 43 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,441,360 | -35.6% | 224,339 | -0.2% | 2.31% | -36.3% |
| Q2 2023 | $5,345,780 | +25.1% | 224,707 | +33.8% | 3.62% | +15.0% |
| Q1 2023 | $4,273,920 | -63.1% | 168,000 | -57.6% | 3.15% | -55.8% |
| Q4 2022 | $11,581,765 | +55.7% | 396,500 | +9.3% | 7.13% | +122.4% |
| Q3 2022 | $7,440,000 | +174.7% | 362,735 | +55.0% | 3.20% | +112.3% |
| Q2 2022 | $2,708,000 | -56.9% | 234,026 | -31.2% | 1.51% | -48.6% |
| Q1 2022 | $6,287,000 | 0.0% | 340,000 | +6.9% | 2.94% | +11.1% |
| Q4 2021 | $6,287,000 | +181.4% | 318,000 | +134.2% | 2.64% | +235.4% |
| Q3 2021 | $2,234,000 | – | 135,807 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $68,684,566 | 13.41% |
| COMMODORE CAPITAL LP | 2,189,659 | $55,704,925 | 8.48% |
| Fairmount Funds Management LLC | 1,369,623 | $34,843,209 | 5.99% |
| Paradigm Biocapital Advisors LP | 2,085,698 | $53,060,157 | 5.03% |
| Octagon Capital Advisors LP | 1,185,000 | $30,146,400 | 4.34% |
| Logos Global Management LP | 950,000 | $24,168,000 | 3.46% |
| TCG Crossover Management, LLC | 663,610 | $16,882,238 | 3.29% |
| ACUTA CAPITAL PARTNERS, LLC | 168,000 | $4,273,920 | 3.15% |
| Vivo Capital, LLC | 1,678,207 | $42,693,586 | 2.96% |
| TANG CAPITAL MANAGEMENT LLC | 692,925 | $17,628,012 | 2.63% |